Investing

How to trade this agriculture stock that rallied on tariff headlines using options

The adjusted earnings per share (EPS) guidance for fiscal 2025 has been set between $7.30 and $7.60, reflecting a slight downward revision from the previous estimate of around $7.75. This new range aligns closely with analyst consensus estimates of $7.47, indicating a careful recalibration rather than a significant deviation from expectations. Initially, the company was slated to report earnings on November 5. Following the announcement, the market reacted positively, with BG shares climbing nearly 13.5% by the end of the trading day. This surge suggests investor relief over the minimal dilution from merger-related adjustments and associated risks.

Interestingly, momentum had begun to shift positively even before this announcement, as the stock’s price action stabilized after a period of decline that started in mid-July. The pressing question now is how investors can best capitalize on this situation. While the short-term momentum appears promising, Bunge may face resistance around the $100 per share mark. This level is significant as it represents the point from which the stock fell after a disappointing outlook was shared during its Q2 results in July 2024.

Pre-announcements typically do not yield substantial upside surprises, and this instance was no exception. Analysts had anticipated a full-year decline in profits by double digits. Bunge now expects earnings to fall within the range of $7.30 to $7.60 per share for the year, which, when taking the midpoint, indicates a nearly 19% decline year-over-year from FY2024. This decline follows a significant 27% drop compared to 2023.

Several headwinds are contributing to this outlook, including fluctuations in global commodity markets, particularly soybean and oilseed prices, which are influenced by weather disruptions and ongoing trade tensions. Additionally, the integration of the $7.3 billion acquisition of Viterra adds another layer of complexity. While Bunge has alleviated immediate uncertainties, it has not introduced new catalysts for sustained growth.

Given the price before the pre-announcement as a potential support level, and considering the resistance at last year’s price point prior to the Q2 gap down, a period of consolidation may be on the horizon. Historical trends in the agribusiness sector suggest that companies like Bunge often exhibit muted volatility following guidance updates that fall within consensus ranges.

Broader macroeconomic pressures in the agricultural sector further reinforce this range-bound outlook. Persistent challenges, such as elevated input costs and weakening demand from key markets like China, continue to squeeze margins across the industry. Recent geopolitical developments, including U.S. trade policy signals, have occasionally boosted sentiment, as evidenced by BG’s gains earlier in October, but these remain speculative.

If we consider the pre-announcement price as support and the level from which the stock gapped down just over a year ago as resistance, one potential strategy could be to sell a December 85/100 strangle. Based on Wednesday’s closing mid-point prices, this approach could yield nearly $5.25 in premium. Annualized, this represents a standstill rate of return exceeding 30%. In a worst-case scenario, one would acquire Bunge shares at just under $80 per share, the put strike minus the premium collected, or short at around $105, the call strike plus the premium collected, reflecting the level from which it fell just over a year ago.

Here are the specifics of this example trade.

DISCLOSURES: None. All opinions expressed by the CNBC Pro contributors are solely their opinions and do not reflect the opinions of CNBC, NBC UNIVERSAL, their parent company or affiliates, and may have been previously disseminated by them on television, radio, internet, or another medium. THE ABOVE CONTENT IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY. THIS CONTENT IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSTITUTE FINANCIAL, INVESTMENT, TAX, OR LEGAL ADVICE OR A RECOMMENDATION TO BUY ANY SECURITY OR OTHER FINANCIAL ASSET. THE CONTENT IS GENERAL IN NATURE AND DOES NOT REFLECT ANY INDIVIDUAL’S UNIQUE PERSONAL CIRCUMSTANCES. THE ABOVE CONTENT MIGHT NOT BE SUITABLE FOR YOUR PARTICULAR CIRCUMSTANCES. BEFORE MAKING ANY FINANCIAL DECISIONS, YOU SHOULD STRONGLY CONSIDER SEEKING ADVICE FROM YOUR OWN FINANCIAL OR INVESTMENT ADVISOR. Click here for the full disclaimer.